Zurueck zur Suche

Reporte zur Charge U030162

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

19Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MI 4 OH 3 KS 2 IL 2 NY 2 PA 1 MA 1 KY 1 GA 1 VA 1

VAERS 2407155

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U030162

moderat
Staat
KS
Alter
36,0
Geschlecht
F
Eingang
10.08.2022
Impfdatum
13.07.2022
Beginn
13.07.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dyspnoea Injection site erythema Injection site pain Injection site pruritus Injection site swelling

Symptomtext

Starting in afternoon after morning vaccine, SOB w use of inhaler to help give relief, pain, redness, swelling, itching at injection site w redness the size of baseball. Injection site symptoms lasted 1 week, SOB decreased in severity over one week. Client took Benadryl daily, also received one "steroid shot" at PCP office that first week (date unknown). Symptoms decreased over time the week after vaccination.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2465694

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U030162

mild
Staat
PA
Alter
56,0
Geschlecht
F
Eingang
30.09.2022
Impfdatum
22.09.2022
Beginn
23.09.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Blister Erythema Pruritus Pustule Skin warm

Symptomtext

Arm started with redness, heat and itching. Progressed to puss-filled blistering of right arm.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
Employee was evaluated at Emergency room and clinic and is scheduled for a follow-up the week of 10/3/2022.
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
Aspirin, Penicillin, mold, dust, ? of Sulfa
Vorherige Impfungen
-

VAERS 2273333

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U030162

mild
Staat
OH
Alter
1,3
Geschlecht
M
Eingang
12.05.2022
Impfdatum
03.05.2022
Beginn
10.05.2022
Tage bis Beginn
7,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash Rash maculo-papular

Symptomtext

Development of maculopapular rash present on medial thighs and abdomen. Nonpruritic and nonpainful. Developed 9 days following vaccine administration.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2259853

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U030162

mild
Staat
IL
Alter
-
Geschlecht
U
Eingang
28.04.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Injection site rash Rash Rash erythematous Rash papular

Symptomtext

Rash started about 12 days after vaccine - papulovesicular rash with slight erythema 8cm x 4cm at injection site R thigh. Spread to trunk after onset

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site rash
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
mild persistent reactive airway disease J45.30
Vorgeschichte
-
Andere Medikamente
Budesonide 0.5mg/2ml Albuterol 1.25mg/3ml
Allergien
none
Vorherige Impfungen
-

VAERS 2698637

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U030162

gering
Staat
IL
Alter
-
Geschlecht
U
Eingang
19.10.2023
Impfdatum
13.10.2023
Beginn
13.10.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

patient is fine. Confirmed no other symptoms or adverse events; administration of VARIVAX that was expired; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 13-OCT-2023, the patient was vaccinated with an expired dose of varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 milliliter, once, lot #U030162 (lot number has been verified as valid for VARIVAX), expiration date: 28-SEP-2023 (strength, anatomical location, and route of administration were not provided) as prophylaxis. It was stated that the patient was fine. No adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2643551

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U030162

gering
Staat
OH
Alter
1,0
Geschlecht
M
Eingang
09.06.2023
Impfdatum
09.09.2022
Beginn
14.09.2022
Tage bis Beginn
5,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Immunisation reaction

Symptomtext

Adverse effect of other vaccines and biological substances, initial encounter on 2022-09-14.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Immunisation reaction
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Encounter for routine child health examination NOS
Vorgeschichte
-
Andere Medikamente
None
Allergien
-
Vorherige Impfungen
-

VAERS 2627666

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U030162

gering
Staat
MA
Alter
7,0
Geschlecht
M
Eingang
05.05.2023
Impfdatum
12.01.2022
Beginn
12.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Circumstance or information capable of leading to medication error Extra dose administered No adverse event

Symptomtext

HCP called to report that she accidentally gave the patient an extra dose of VARIVAX. No additional AE/PQC; HCP called to report that she accidentally gave the patient an extra dose of VARIVAX. No additional AE/PQC; third dose of VAQTA on 6/21/2022; fourth dose of MMR II on 4/19/2022; third dose of MMR II on 1/12/2022; This spontaneous report was received from a registered nurse and refers to a 7-year-old male patient with milk protein and soy allergies, neonatal abstinence syndrome, neonatal stroke, attention deficit hyperactivity disorder (ADHD), and autism. His medical history was not reported. Concomitant medications included sterile diluent (STERILE DILUENT), diphtheria vaccine toxoid (+) pertussis vaccine acellular (+) tetanus vaccine toxoid (DTAP) and hepatitis b vaccine (HEP-B-VAX). He had no adverse event following prior vaccination. On an unknown date, the patient was vaccinated with the third dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot #U030162, expiration date: 28-SEP-2023, administered subcutaneously in right arm (dose was not provided). On 12-JAN-2022, he was administered with the third dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection, 0.5 milliliter, lot #T033815, expiration date: 05-OCT-2022, administered subcutaneously in right arm (extra dose administered). Then, on 19-APR-2022, he received the fourth dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection, 0.5 milliliter, lot #T034392, expiration date: 08-OCT-2022, administered subcutaneously in right arm (extra dose administered). On that date, the patient was also administered with polio vaccine. On 21-JUN-2022, the patient received the third dose of hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, 0.5 milliliter, lot #U024505, expiration date: 15-OCT-2022, administered intramuscularly in left deltoid (extra dose administered). The HCP said the patient went to a different pediatrician in 2022, and the pediatrician was unsure of the patient's vaccination history. So, due to the unknown vaccination history (incomplete and inaccurate vaccine documentation), the patient received these extra doses of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) and hepatitis a vaccine, inactivated (VAQTA) in 2022. On 06-APR-2023, the patient was accidentally vaccinated with the fourth dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot #W024335, expiration date: 01-AUG-2024, administered subcutaneously in left arm (extra dose administered). All vaccines were administered for prophylaxis. No adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Circumstance or information capable of leading to medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Attention deficit hyperactivity disorder; Autism; Milk protein allergy; Neonatal abstinence syndrome; Perinatal stroke; Prophylaxis; Soy allergy
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT; DTAP; HEP-B-VAX
Allergien
-
Vorherige Impfungen
-

VAERS 2562286

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge u030162

gering
Staat
KY
Alter
35,0
Geschlecht
F
Eingang
18.01.2023
Impfdatum
16.01.2023
Beginn
16.01.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered No adverse event

Symptomtext

Pt was given a 3rd dose of the 2-dose series of varicella. Provider was notified. Then Patient was then contacted, denies sign and symptoms of reaction to varicella vaccine. Educated pt on what to assess for.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
Hypertension Depression
Andere Medikamente
Norvasc 10 mg Loratadine 10 mg Hydrochlorothiazide 12.5 mg Ibuprofen 600 mg Vitamin D2 1.25 MG Buspirone 5 MG Ozempic 0.25-0.5-dose Vitamin C 500 mg
Allergien
Morphine Imitrex Penicillin
Vorherige Impfungen
-

VAERS 2452925

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U030162

gering
Staat
NY
Alter
1,0
Geschlecht
M
Eingang
21.09.2022
Impfdatum
27.06.2022
Beginn
27.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No other AE; Caller is a nurse who reports that PROQUAD and VARIVAX may have been given after a temperature excursion that occurred in April 2022. Vaccines were then sent back so she does not have time/temperature data and does not know whether any vac; This spontaneous report was received from a registered nurse and refers to a 12-month-old male patient. Information regarding the patient's concurrent conditions, medical history, historical drugs and concomitant therapies was not provided. On 27-JUN-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot #U030162, expiration date: 28-SEP-2023, administered subcutaneously in the right arm for prophylaxis (product storage error), it was mentioned that there was not previous temperature excursion. No additional adverse event was reported. This is one of four reports received from the same reporter.; Sender's Comments: US-009507513-2208USA009203: US-009507513-2209USA003332: US-009507513-2209USA003333:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2418210

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge u030162

gering
Staat
MI
Alter
1,0
Geschlecht
F
Eingang
23.08.2022
Impfdatum
23.08.2022
Beginn
23.08.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Inappropriate schedule of product administration

Symptomtext

Polio vaccine was given two soon. Given on 8/23/2022, not due until 8/5/2025

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
CF carrier
Andere Medikamente
none
Allergien
NKA
Vorherige Impfungen
-

VAERS 2415556

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U030162

gering
Staat
NY
Alter
1,0
Geschlecht
F
Eingang
19.08.2022
Impfdatum
30.07.2022
Beginn
30.07.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported.; Nurse calling in TE case 02215786 reports 1 dose of VARIVAX stored outside of recommended range administered to 1 patient.; This spontaneous report was received from a nurse and refers to an 1-year-old female patient. The patient's medical history, current conditions and concomitant medications were not reported. On 30-JUL-2022, the patient was vaccinated with 1 dose of improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) lot #U030162, expiration date: 28-SEP-2023 (anatomical location and route of administration were not provided) for prophylaxis, after the temperature excursion happened (Improper storage of product in use). Administrated vaccine varicella virus vaccine live (oka/merck) (VARIVAX) was stored at 35 Fahrenheit (F) for 1 hour and 59 minutes. There was no previous temperature excursion. There were no adverse events reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2328925

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U030162

gering
Staat
-
Alter
56,0
Geschlecht
F
Eingang
23.06.2022
Impfdatum
10.06.2022
Beginn
10.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect route of product administration No adverse event

Symptomtext

IM injection given SC route. patient was observed for 45 minutes; no adverse event occurred;

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2319096

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U030162

gering
Staat
MI
Alter
4,0
Geschlecht
F
Eingang
14.06.2022
Impfdatum
13.06.2022
Beginn
13.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SC / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered No adverse event Wrong product administered

Symptomtext

Pentacel given instead of Kinrix Patient received an extra dose of Hib No known adverse effects

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
NKA
Vorherige Impfungen
-

VAERS 2318772

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U030162

gering
Staat
MI
Alter
1,5
Geschlecht
F
Eingang
14.06.2022
Impfdatum
10.06.2022
Beginn
10.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SC / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age

Symptomtext

Adult Hep. A given to child

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
None
Allergien
NONE
Vorherige Impfungen
-

VAERS 2317340

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U030162

gering
Staat
MI
Alter
1,4
Geschlecht
M
Eingang
13.06.2022
Impfdatum
13.06.2022
Beginn
13.06.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered

Symptomtext

Patient was given adult dose of Hep A, Instead of pediatric dose. Patient did not show any signs or symptoms before leaving the office.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
None at this time.
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2314028

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U030162

gering
Staat
GA
Alter
1,3
Geschlecht
M
Eingang
09.06.2022
Impfdatum
08.06.2022
Beginn
09.06.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Extra dose administered

Symptomtext

On 6/8/2022 patient received two doses of Varicella, mistakenly. No adverse reaction has been reported at this time. Doctor has informed mother of event and informed to call office or go to ER with any site reaction, fever, HA, excessive fussiness, or seizure. Again at this time mother reports no adverse reaction.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
tylenol was administered at the time of vaccines administration
Allergien
no known allergies
Vorherige Impfungen
-

VAERS 2309778

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U030162

gering
Staat
OH
Alter
1,0
Geschlecht
U
Eingang
06.06.2022
Impfdatum
13.05.2022
Beginn
13.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered

Symptomtext

Concomitant administration of VARIVAX and PROQUAD to a one year old patient.; This spontaneous report was received from a medical assistant concerning a 1-year-old patient of unknown gender. The patient's pertinent medical history, concurrent conditions and concomitant medications were not provided. On 13-MAY-2022, the patient was vaccinated concomitantly with varicella virus vaccine live (Oka/Merck) (VARIVAX) 0.5 milliliter (ml), lot # U030162, expiration date 28-SEP-2023, and Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) 0.5 ml, lot # U0315694, expiration date 06-APR-2023, for prophylaxis (route of administration and anatomical location was not reported) (Overdose). No additional information was provided. Lot number U0315694 is an invalid lot number for Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD). Lot number U0315694 does not match any Company product as confirmed by Lot Verification team.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278321

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge u030162

gering
Staat
VA
Alter
22,0
Geschlecht
M
Eingang
16.05.2022
Impfdatum
16.05.2022
Beginn
16.05.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect route of product administration No adverse event

Symptomtext

RN gave Varicella and MMR vaccines intra-muscular vs subcutaneous. Patient did not experience an adverse event after receiving the vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2277750

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U030162

gering
Staat
KS
Alter
38,0
Geschlecht
M
Eingang
14.05.2022
Impfdatum
14.05.2022
Beginn
14.05.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Incorrect route of product administration

Symptomtext

Varicella vaccine was given via IM route instead of SC route.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-